000 01687 a2200529 4500
005 20250514064723.0
264 0 _c20030520
008 200305s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.11340
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aComings, David E
245 0 0 _aA multigene test for the risk of sporadic breast carcinoma.
_h[electronic resource]
260 _bCancer
_cMay 2003
300 _a2160-70 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAge Distribution
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aBreast Neoplasms
_xetiology
650 0 4 _aCase-Control Studies
650 0 4 _aCatechol O-Methyltransferase
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aLeptin
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aPolymorphism, Genetic
650 0 4 _aROC Curve
650 0 4 _aReceptors, Androgen
_xgenetics
650 0 4 _aReceptors, Cell Surface
_xgenetics
650 0 4 _aReceptors, Dopamine D2
_xgenetics
650 0 4 _aReceptors, Estrogen
_xgenetics
650 0 4 _aReceptors, Leptin
650 0 4 _aRisk Factors
650 0 4 _aSensitivity and Specificity
700 1 _aGade-Andavolu, Radhika
700 1 _aCone, Lawrence A
700 1 _aMuhleman, Donn
700 1 _aMacMurray, James P
773 0 _tCancer
_gvol. 97
_gno. 9
_gp. 2160-70
856 4 0 _uhttps://doi.org/10.1002/cncr.11340
_zAvailable from publisher's website
999 _c12503543
_d12503543